1. Home
  2. CRIS vs OPAD Comparison

CRIS vs OPAD Comparison

Compare CRIS & OPAD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRIS
  • OPAD
  • Stock Information
  • Founded
  • CRIS 2000
  • OPAD 2015
  • Country
  • CRIS United States
  • OPAD United States
  • Employees
  • CRIS N/A
  • OPAD N/A
  • Industry
  • CRIS Biotechnology: Biological Products (No Diagnostic Substances)
  • OPAD Real Estate
  • Sector
  • CRIS Health Care
  • OPAD Finance
  • Exchange
  • CRIS Nasdaq
  • OPAD Nasdaq
  • Market Cap
  • CRIS 21.3M
  • OPAD 25.3M
  • IPO Year
  • CRIS 2000
  • OPAD N/A
  • Fundamental
  • Price
  • CRIS $1.83
  • OPAD $1.44
  • Analyst Decision
  • CRIS Strong Buy
  • OPAD Hold
  • Analyst Count
  • CRIS 2
  • OPAD 5
  • Target Price
  • CRIS $16.50
  • OPAD $2.38
  • AVG Volume (30 Days)
  • CRIS 153.7K
  • OPAD 133.6K
  • Earning Date
  • CRIS 07-31-2025
  • OPAD 08-04-2025
  • Dividend Yield
  • CRIS N/A
  • OPAD N/A
  • EPS Growth
  • CRIS N/A
  • OPAD N/A
  • EPS
  • CRIS N/A
  • OPAD N/A
  • Revenue
  • CRIS $11,202,000.00
  • OPAD $794,159,000.00
  • Revenue This Year
  • CRIS N/A
  • OPAD N/A
  • Revenue Next Year
  • CRIS $10.67
  • OPAD $40.79
  • P/E Ratio
  • CRIS N/A
  • OPAD N/A
  • Revenue Growth
  • CRIS 14.17
  • OPAD N/A
  • 52 Week Low
  • CRIS $1.02
  • OPAD $0.91
  • 52 Week High
  • CRIS $8.29
  • OPAD $5.13
  • Technical
  • Relative Strength Index (RSI)
  • CRIS 39.33
  • OPAD 71.45
  • Support Level
  • CRIS $1.50
  • OPAD $0.91
  • Resistance Level
  • CRIS $1.98
  • OPAD $1.54
  • Average True Range (ATR)
  • CRIS 0.20
  • OPAD 0.12
  • MACD
  • CRIS -0.06
  • OPAD 0.06
  • Stochastic Oscillator
  • CRIS 30.84
  • OPAD 79.37

About CRIS Curis Inc.

Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

About OPAD Offerpad Solutions Inc.

Offerpad Solutions Inc provides a way to buy and sell a home. It uses technology-enabled solutions to remake the home selling and buying experience by offering customers the convenience, control, and certainty to solve their housing needs. It combines fundamental real estate expertise with the data-driven digital Solutions Center platform to efficiently sell and buy their homes online with streamlined access to other services including mortgage, listing, renovation and buyer representation services.

Share on Social Networks: